Spots Global Cancer Trial Database for SPECTAbrain: Screening Patients With Brain Tumors for Efficient Clinical Trial Access
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: SPECTAbrain: Screening Patients With Brain Tumors for Efficient Clinical Trial Access
Official Title: Screening Platform of EORTC for Clinical Trials Access in Brain Tumors
Study ID: NCT02307604
Conditions
Interventions
Study Description
Brief Summary: The SPECTAbrain protocol describes a structure for screening patients with brain tumors to efficiently allocate eligible patients in relevant therapeutic biomarker-driven clinical trials. Efficiency is promoted through the creation of a clinical database of brain tumor patients and the respective human biological material biobank for molecular characterization. The main objectives are to: * Allocate patients to clinical trials according to the clinical characteristics and molecular profile of their tumor; * Identify or validate new molecularly defined subgroups of tumors; * Investigate the prevalence of novel biomarkers to plan future clinical trials; * Enable exploratory/future research; * Facilitate establishment of quality-assured and validated tests for Central Nervous System (CNS) tumor biomarkers;
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
CHRU de Lille, Lille, , France
Assistance Publique - Hopitaux de Paris - La Pitie Salpetriere, Paris, , France
Contact Details
Name: Michael Weller, MD
Affiliation: UniversitaetsSpital Zurich - Department of Neurology, Zurich, Switzerland
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
